L.Desjardins submits:
Despite a disappointing land auction on Wednesday, Hong Kong property stocks kept their upward momentum, gaining 3% on the week, again the best sector in the Hang Seng Index. The introduction of new measures to cool the mainland property market were even received positively by Hong Kong investors, seeing these measures as less [...]
Econ Grapher submits:
This week we review the apparent rebound in the Chinese manufacturing sector, followed by a look at the quarterly Tankan survey results from Japan. Then we look at the U.S. PMI results which show grim signs; as do the housing and confidence figures. Finally we wrap up with a look at some other [...]
Stone Fox Capital submits:
ChinaCache Internaitonal (CCIH) hasn’t gotten alot of attention on the IPO circuit due to its history of losses. Ironically though this mostly ignored IPO priced above the expected $10-12 range Thursday night at $13.90 showing significant demand. Not to mention they upped the shares by roughly 10% as [...]
ChinaBio Today submits:
Shanghai Roche Pharma, the first China JV set up by Roche (RHHBY.PK), officially announced on its website that its cancer treatment Avastin has been approved for sale in China. The announcement comes after Avastin received negative publicity in China. Apparently, a fake version of Avastin caused adverse reactions in 61 patients [...]
Ian Wyatt submits:
We’re in the home stretch of 2010. The favorite, Weak Recovery, is ahead by a nose. QE2 and Falling Dollar are right behind. Toxic Asset and Solid Earnings have been unable to mount a charge.
But two horses — Man ‘o Trade War and Europe’s Problem — are [...]